000 01258 a2200361 4500
005 20250513082930.0
264 0 _c19930722
008 199307s 0 0 eng d
022 _a0901-9928
024 7 _a10.1111/j.1600-0773.1993.tb00308.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHall, H
245 0 0 _aBinding of [3H]SCH 39166 to human post mortem brain tissue.
_h[electronic resource]
260 _bPharmacology & toxicology
_cMar 1993
300 _a152-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAutoradiography
650 0 4 _aBenzazepines
_xmetabolism
650 0 4 _aBinding, Competitive
650 0 4 _aBrain
_xmetabolism
650 0 4 _aDopamine Antagonists
650 0 4 _aFlupenthixol
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRadioligand Assay
650 0 4 _aReceptors, Dopamine D1
_xmetabolism
700 1 _aHalldin, C
700 1 _aSedvall, G
773 0 _tPharmacology & toxicology
_gvol. 72
_gno. 3
_gp. 152-8
856 4 0 _uhttps://doi.org/10.1111/j.1600-0773.1993.tb00308.x
_zAvailable from publisher's website
999 _c8515519
_d8515519